Evans M I, Littman L, Richter R, Richter K, Hume R F
Department of Obstetrics and Gynecology, Hutzel Hospital/Wayne State University, Detroit, Michigan 48201, USA.
J Reprod Med. 1997 Dec;42(12):771-7.
Multifetal pregnancy reduction has emerged as a staple of infertility therapy. With increasing utilization of aggressive infertility therapies, thousands of couples have been able to achieve pregnancies who otherwise would not have, but an increasing number and proportion of patients have multifetal pregnancies. Multifetal pregnancy reduction (MFPR) has been shown to be a safe and effective treatment for reducing the number of pregnancies, thereby reducing both perinatal morbidity and mortality in resultant pregnancies. The world experience suggests that the risks of MFPR are directly related to the starting number of fetuses but that in the majority of instances, healthy children can be achieved.
多胎妊娠减胎术已成为不孕不育治疗的一项主要手段。随着激进的不孕不育治疗方法的使用日益增加，成千上万原本无法怀孕的夫妇得以成功受孕，但多胎妊娠的患者数量及其所占比例也在不断上升。多胎妊娠减胎术（MFPR）已被证明是一种安全有效的治疗方法，可减少妊娠数量，从而降低由此产生的妊娠中围产期发病率和死亡率。全球经验表明，多胎妊娠减胎术的风险与起始胎儿数量直接相关，但在大多数情况下，可以诞下健康的婴儿。
